ClinicalTrials.Veeva

Menu

Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy (ISAR-WAVE)

G

German Heart Center Munich

Status

Enrolling

Conditions

Coronary Artery Disease

Treatments

Device: Standard non-IVL methods
Device: Intravascular lithotripsy (IVL)

Study type

Interventional

Funder types

Other

Identifiers

NCT06369142
GE IDE No. L00123

Details and patient eligibility

About

The clinical trial is intended to evaluate the efficacy, safety and economic benefit of coronary lithotripsy compared to other additional procedures (cutting or super high pressure balloon angioplasty, ablative procedures) in lesion preparation and interventional treatment of severely calcified coronary stenoses.

Enrollment

666 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. age ≥18 years and able to give informed consent
  2. written informed consent to participate in the clinical trial
  3. typical angina pectoris or non-invasive evidence of relevant ischemia under optimal drug therapy
  4. angiographic evidence of coronary artery disease
  5. de novo lesion in a native coronary artery
  6. target vessel diameter 2.5-4 mm
  7. severe calcification of the target lesion (angiographic grade 3)

Exclusion criteria

  1. myocardial infarction <1 week
  2. thrombus in the target vessel
  3. life expectancy due to other disease <1 year
  4. simultaneous participation in a clinical trial with medical devices or medicinal products that has not yet been completed
  5. pregnancy (current, suspected, planned) or positive pregnancy test

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

666 participants in 2 patient groups

Lesion preparation using coronary intravascular lithotripsy
Experimental group
Treatment:
Device: Intravascular lithotripsy (IVL)
Lesion preparation using other methods than intravascular lithotripsy
Active Comparator group
Description:
e.g. cutting or super high pressure balloons and/or ablative procedures
Treatment:
Device: Standard non-IVL methods

Trial contacts and locations

22

Loading...

Central trial contact

Salvatore Cassese, MD, PHD; Thorsten Kessler, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems